|
🐜
|
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study
15 auth.
M. Shrotri,
M. Krutikov,
T. Palmer,
R. Giddings,
B. Azmi,
S. Subbarao,
C. Fuller,
A. Irwin-Singer,
D. Davies,
G. Tut,
...
J. Lopez Bernal,
P. Moss,
A. Hayward,
A. Copas,
L. Shallcross
|
7 |
2021 |
7
🐜
|
|
🐜
|
Factors associated with SARS-CoV-2 infection and outbreaks in long-term care facilities in England: a national cross-sectional survey
11 auth.
L. Shallcross,
Danielle Burke,
O. Abbott,
A. Donaldson,
Gemma Hallatt,
A. Hayward,
...
S. Hopkins,
M. Krutikov,
Katie Sharp,
Leone Wardman,
Sapphira R. Thorne
|
6 |
2021 |
6
🐜
|
|
🦁
|
Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England
15 auth.
M. Krutikov,
T. Palmer,
G. Tut,
C. Fuller,
B. Azmi,
R. Giddings,
M. Shrotri,
N. Kaur,
P. Sylla,
T. Lancaster,
...
A. Irwin-Singer,
A. Hayward,
P. Moss,
A. Copas,
L. Shallcross
|
6 |
2021 |
6
🦁
|
|
🐜
|
Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings
37 auth.
Rishi K. Gupta,
C. Calderwood,
A. Yavlinsky,
M. Krutikov,
Matteo Quartagno,
M. C. Aichelburg,
N. Altet,
R. Diel,
C. Dobler,
J. Domínguez,
J. Doyle,
C. Erkens,
S. Geis,
P. Haldar,
A. Hauri,
...
T. Hermansen,
J. Johnston,
C. Lange,
B. Lange,
F. van Leth,
L. Muñoz,
C. Roder,
K. Romanowski,
D. Roth,
M. Sester,
R. Sloot,
G. Sotgiu,
G. Woltmann,
T. Yoshiyama,
J. Zellweger,
D. Zenner,
R. Aldridge,
A. Copas,
M. Rangaka,
M. Lipman,
M. Noursadeghi,
I. Abubakar
|
6 |
2020 |
6
🐜
|
|
🐜
|
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of Long-Term Care Facilities (VIVALDI study)
15 auth.
M. Shrotri,
M. Krutikov,
T. Palmer,
R. Giddings,
B. Azmi,
S. Subbarao,
C. Fuller,
A. Irwin-Singer,
D. Davies,
G. Tut,
...
J. L. Bernal,
P. Moss,
A. Hayward,
A. Copas,
L. Shallcross
|
5 |
2021 |
5
🐜
|
|
🦁
|
Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI): a prospective cohort study
13 auth.
M. Krutikov,
T. Palmer,
G. Tut,
C. Fuller,
M. Shrotri,
H. Williams,
D. Davies,
A. Irwin-Singer,
J. Robson,
A. Hayward,
...
P. Moss,
A. Copas,
L. Shallcross
|
5 |
2021 |
5
🦁
|
|
🦁
|
The diagnostic performance of novel skin-based in-vivo tests for tuberculosis infection compared with purified protein derivative tuberculin skin tests and blood-based in vitro interferon-γ release assays: a systematic review and meta-analysis.
10 auth.
M. Krutikov,
L. Faust,
V. Nikolayevskyy,
Y. Hamada,
Rishi K. Gupta,
D. Cirillo,
...
A. Mateelli,
A. Korobitsyn,
C. Denkinger,
M. Rangaka
|
5 |
2021 |
5
🦁
|
|
🦁
|
Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study
14 auth.
M. Krutikov,
Oliver T. Stirrup,
H. Nacer-Laidi,
B. Azmi,
C. Fuller,
G. Tut,
T. Palmer,
M. Shrotri,
A. Irwin-Singer,
V. Baynton,
...
A. Hayward,
P. Moss,
A. Copas,
L. Shallcross
|
5 |
2022 |
5
🦁
|
|
🐜
|
Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study
22 auth.
G. Tut,
T. Lancaster,
M. Krutikov,
P. Sylla,
David Bone,
N. Kaur,
E. Spalkova,
Christopher Bentley,
U. Amin,
A. Jadir,
...
Samuel Hulme,
M. Butler,
M. Ayodele,
R. Bruton,
M. Shrotri,
B. Azmi,
C. Fuller,
A. Irwin-Singer,
A. Hayward,
A. Copas,
L. Shallcross,
P. Moss
|
5 |
2021 |
5
🐜
|
